BBNX Long Put Strategy

BBNX (Beta Bionics, Inc.), in the Healthcare sector, (Medical - Equipment & Services industry), listed on NASDAQ.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

BBNX (Beta Bionics, Inc.) trades in the Healthcare sector, specifically Medical - Equipment & Services, with a market capitalization of approximately $429.1M, a beta of 3.28 versus the broader market, a 52-week range of 8.8-32.71, average daily share volume of 1.1M, a public-listing history dating back to 2025, approximately 352 full-time employees. These structural characteristics shape how BBNX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 3.28 indicates BBNX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on BBNX?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current BBNX snapshot

As of May 15, 2026, spot at $9.32, ATM IV 141.40%, expected move 40.54%. The long put on BBNX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long put structure on BBNX specifically: IV rank is unavailable in the current snapshot, so regime-based timing for BBNX is inferred from ATM IV at 141.40% alone, with a market-implied 1-standard-deviation move of approximately 40.54% (roughly $3.78 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BBNX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BBNX should anchor to the underlying notional of $9.32 per share and to the trader's directional view on BBNX stock.

BBNX long put setup

The BBNX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BBNX near $9.32, the first option leg uses a $9.32 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BBNX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BBNX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$9.32N/A

BBNX long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

BBNX long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on BBNX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on BBNX

Long puts on BBNX hedge an existing long BBNX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying BBNX exposure being hedged.

BBNX thesis for this long put

The market-implied 1-standard-deviation range for BBNX extends from approximately $5.54 on the downside to $13.10 on the upside. A BBNX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long BBNX position with one put per 100 shares held. As a Healthcare name, BBNX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BBNX-specific events.

BBNX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BBNX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BBNX alongside the broader basket even when BBNX-specific fundamentals are unchanged. Long-premium structures like a long put on BBNX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BBNX chain quotes before placing a trade.

Frequently asked questions

What is a long put on BBNX?
A long put on BBNX is the long put strategy applied to BBNX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With BBNX stock trading near $9.32, the strikes shown on this page are snapped to the nearest listed BBNX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BBNX long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the BBNX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 141.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BBNX long put?
The breakeven for the BBNX long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BBNX market-implied 1-standard-deviation expected move is approximately 40.54%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on BBNX?
Long puts on BBNX hedge an existing long BBNX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying BBNX exposure being hedged.
How does current BBNX implied volatility affect this long put?
Current BBNX ATM IV is 141.40%; IV rank context is unavailable in the current snapshot.

Related BBNX analysis